Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4

Reference

• Naccache JM, Gibiot Q, Monnet I, et al. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10:3829–3844.
   PubMed Web of Science ®Google Scholar
• Hidayat K, Du X, Chen G, et al. Abdominal obesity and lung cancer risk: systematic review and meta-analysis of prospective studies. Nutrients 2016;8:810.
   PubMed Web of Science ®Google Scholar
• Huang CY, Ju DT, Chang CF, et al. A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei). 2017;7:23.
   PubMedGoogle Scholar
• Liu ZL, Zhu WR, Zhou WC, et al. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis. J Integr Med. 2014;12:346–358.
   PubMedGoogle Scholar
• Zhao B, Zhang W. Reply to the comments on Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: a systematic review and meta-analysis of randomized clinical trials. Lung Cancer. 2018;126:225–226.
   PubMed Web of Science ®Google Scholar
• Criss SD, Mooradian MJ, Sheehan DF, et al. Cost-effectiveness and budgetary consequence analysis of Durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the US health care system. JAMA Oncol. 2018;5:.
   Web of Science ®Google Scholar
• Duruisseaux M, Martinez-Cardus A, Calleja-Cervantes ME, et al. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis. Lancet Respir Med. 2018;6:771–781.
   PubMed Web of Science ®Google Scholar
• Qin J, Zeng N, Yang T, et al. Diagnostic value of autoantibodies in lung cancer: a systematic review and meta-analysis. Cell Physiol Biochem. 2018;51:2631–2646.
   PubMedGoogle Scholar
• Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 2018;172:393–407.
   PubMed Web of Science ®Google Scholar
• Fayda M, Isin M, Tambas M, et al. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Tumour Biol. 2016;37:3969–3978.
   PubMedGoogle Scholar
• Sun Y, Qin B. Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells. Cancer Med. 2018;7:4584–4597.
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Maruyama R, Niinuma T, et al. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1. Cell Death Dis. 2018;9:826.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang X, Yang C, et al. The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC. Cell Cycle. 2018;17:1772–1783.
   PubMed Web of Science ®Google Scholar
• Gong W, Cao Y, Wang Y, et al. Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC. Pathol Res Pract. 2018;214:857–861.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen WJ, Gan TQ, et al. Clinical significance and effect of lncRNA HOXA11-AS in NSCLC: a study based on bioinformatics, in vitro and in vivo verification. Sci Rep. 2017;7:5567.
   PubMed Web of Science ®Google Scholar
• Wang R, Dong HX, Zeng J, et al. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC. J Cell Physiol. 2018;233:7447–7456.
   PubMed Web of Science ®Google Scholar
• Feng H, Zhang J, Shi Y, et al. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival. J Cell Biochem. 2018;:2119–2124.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao K, Xu X, et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9:4475.
   PubMed Web of Science ®Google Scholar
• Garitano-Trojaola A, Jose-Eneriz ES, Ezponda T, et al. Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells. Oncotarget 2018;9:12842–12852.
   PubMedGoogle Scholar
• Li L, Zhang GQ, Chen H, et al. Plasma and tumour levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Oncotarget 2016;7:71773–71781.
   PubMedGoogle Scholar
• Xu R, Feng F, Yu X, et al. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma. Cell Prolif. 2018;51:e12515.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian W, Wang S, et al. Analysis of lncRNA-associated ceRNA network reveals potential lncRNA biomarkers in human Colon Adenocarcinoma. Cell Physiol Biochem. 2018;49:1778–1791.
   PubMed Web of Science ®Google Scholar
• Zhao J, Xu J, Shang AQ, et al. A Six-LncRNA expression signature associated with prognosis of colorectal cancer patients. Cell Physiol Biochem. 2018;50:1882–1890.
   PubMed Web of Science ®Google Scholar
• Pan C, Yao G, Liu B, et al. Long noncoding RNA FAL1 promotes cell proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2017;43:339–352.
   PubMed Web of Science ®Google Scholar
• Shi X, Liu Z, Liu Z, et al. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. EBioMedicine 2018;37:177–187.
   PubMed Web of Science ®Google Scholar
• Xia H, Jing H, Li Y, et al. Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis. Biomed Pharmacother. 2018;106:156–162.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xiao G, Chen Y, et al. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Anticancer Drugs. 2018; 29:725–735.
   PubMed Web of Science ®Google Scholar
• Liu S, Duan W. Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145. J Cell Biochem. 2018;28:8272–8279.
   Google Scholar